Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Jul;58(1):180–189. doi: 10.1172/JCI108448

Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.

J G Thoene, R G Oshima, J C Crawhall, D L Olson, J A Schneider
PMCID: PMC333169  PMID: 932205

Abstract

Certain aminothiols rapidly deplete cultured cystinotic skin fibroblasts of their abnormally high free (nonprotein) cystine pool. The free cystine content of these cells if reduced by over 90% in 1 h with 0.1 mM cysteamine. This is more rapid than previously known methods of removing free cystine from cystinotic fibroblasts. The disulfide, cystamine, is also able to deplete cystinotic cells of free cystine. A patient with nephropathic cystinosis and end-stage renal disease was treated with cysteamine, both intravenously and orally. Both methods of administration rapidly lowered the free cystine content of the patient's peripheral leukocytes. Study of the patient's urinary sulfur excretion did not conclusively determine the effect of this therapy on the total body cystine pool. Her renal status remained at end stage after 1 mo of oral cysteamine, when an episode of grand mal seizures prompted cessation of the study. Determination of the proper place of aminothiol therapy in this disease will depend upon further clinical trial with patients whose kidney function has not deteriorated to the point of irreversible change, accompanied by careful monitoring of plasma aminothiol levels.

Full text

PDF
180

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATFIELD G. N., MORRIS C. J. Analytical separations by highvoltage paper electrophoresis. Amino acids in protein hydrolysates. Biochem J. 1961 Dec;81:606–614. doi: 10.1042/bj0810606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CRAWHALL J. C., THOMPSON C. J. CYSTINURIA: EFFECT OF D-PENICILLAMINE ON PLASMA AND URINARY CYSTINE CONCENTRATIONS. Science. 1965 Mar 19;147(3664):1459–1460. doi: 10.1126/science.147.3664.1459. [DOI] [PubMed] [Google Scholar]
  3. Crawhall J. C., Lietman P. S., Schneider J. A., Seegmiller J. E. Cystinosis. Plasma cystine and cysteine concentrations and the effect of D-penicillamine and dietary treatment. Am J Med. 1968 Mar;44(3):330–339. doi: 10.1016/0002-9343(68)90104-6. [DOI] [PubMed] [Google Scholar]
  4. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ERIKSEN L. A simple method for the preparation of protoporphyrin from washed erythrocytes. Scand J Clin Lab Invest. 1954;6(1):49–50. [PubMed] [Google Scholar]
  6. Ehrenreich B. A., Cohn Z. A. The fate of peptides pinocytosed by macrophages in vitro. J Exp Med. 1969 Jan 1;129(1):227–245. doi: 10.1084/jem.129.1.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Floersheim G. L. Rifampicin and cysteamine protect against the mushroom toxin phalloidin. Experientia. 1974 Nov 15;30(11):1310–1312. doi: 10.1007/BF01945202. [DOI] [PubMed] [Google Scholar]
  8. Goldman H., Scriver C. R., Aaron K., Pinsky L. Use of dithiothreitol to correct cystine storage in cultured cystinotic fibroblasts. Lancet. 1970 Apr 18;1(7651):811–812. doi: 10.1016/s0140-6736(70)92411-6. [DOI] [PubMed] [Google Scholar]
  9. Kroll W. A., Becker F. L., Schneider J. A. Measurement of intracellular amino acids in cultured skin fibroblasts. The effect of storage on cystine recovery and evaluation of three methods of cell preparation. Biochem Med. 1974 Aug;10(4):368–373. doi: 10.1016/0006-2944(74)90040-4. [DOI] [PubMed] [Google Scholar]
  10. Kroll W. A., Schneider J. A. Decrease in free cystine content of cultured cystinotic fibroblasts by ascorbic acid. Science. 1974 Dec 13;186(4168):1040–1042. doi: 10.1126/science.186.4168.1040. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Lee P. L. Single-column system for accelerated amino acid analysis of physiological fluids using five lithium buffers. Biochem Med. 1974 Jun;10(2):107–121. doi: 10.1016/0006-2944(74)90013-1. [DOI] [PubMed] [Google Scholar]
  13. MUNDY R. L., HEIFFER M. H., LEIFHEIT H. C. Blood and urine sulfhydryl and disulfide levels after large doses of betamercaptoethylamine (MEA) or cystamine. Radiat Res. 1961 Apr;14:421–425. [PubMed] [Google Scholar]
  14. MUNDY R. L., HEIFFER M. H. The pharmacology of radioprotectant chemicals. General pharmacology of beta-mercapto-ethylamine. Radiat Res. 1960 Sep;13:381–394. [PubMed] [Google Scholar]
  15. Mitchell J. R., Thorgeirsson S. S., Potter W. Z., Jollow D. J., Keiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974 Oct;16(4):676–684. doi: 10.1002/cpt1974164676. [DOI] [PubMed] [Google Scholar]
  16. NOVELLI G. D., SCHMETZ F. J., Jr, KAPLAN N. O. Enzymatic degradation and resynthesis of coenzyme A. J Biol Chem. 1954 Feb;206(2):533–545. [PubMed] [Google Scholar]
  17. Oshima R. G., Willis R. C., Furlong C. E., Schneider J. A. Binding assays for amino acids. The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples. J Biol Chem. 1974 Oct 10;249(19):6033–6039. [PubMed] [Google Scholar]
  18. PIHL A., ELDJARN L., BREMER J. On the mode of action of x-ray protective agents. III. The enzymatic reduction of disulfides. J Biol Chem. 1957 Jul;227(1):339–345. [PubMed] [Google Scholar]
  19. Poole J. R., Mudd S. H., Conerly E. B., Edwards W. A. Homocystinuria due to cystathionine synthase deficiency. Studies of nitrogen balance and sulfur excretion. J Clin Invest. 1975 May;55(5):1033–1048. doi: 10.1172/JCI108004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Prescott L. F., Newton R. W., Swainson C. P., Wright N., Forrest A. R., Matthew H. Successful treatment of severe paracetamol overdosage with cysteamine. Lancet. 1974 Apr 6;1(7858):588–592. doi: 10.1016/s0140-6736(74)92649-x. [DOI] [PubMed] [Google Scholar]
  21. Rodríguez de Lores Arn, Alberici de Canal M., Robiolo B., Mistrorigo de Pacheco M. The effect of the convulsant 3-mercaptopropionic acid on enzymes of the gamma-aminobutyrate system in the rat cerebral cortex. J Neurochem. 1973 Sep;21(3):615–623. doi: 10.1111/j.1471-4159.1973.tb06006.x. [DOI] [PubMed] [Google Scholar]
  22. Schneider J. A., Rosenbloom F. M., Bradley K. H., Seegmiller J. E. Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochem Biophys Res Commun. 1967 Nov 30;29(4):527–531. doi: 10.1016/0006-291x(67)90516-5. [DOI] [PubMed] [Google Scholar]
  23. Schulman J. D., Bradley K. H. Cystinosis: selective induction of vacuolation in fibroblasts by L-cysteine-D-penicillamine disulfide. Science. 1970 Aug 7;169(3945):595–597. doi: 10.1126/science.169.3945.595. [DOI] [PubMed] [Google Scholar]
  24. Schulman J. D., Bradley K. H. Cystinosis: therapeutic implications of in vitro studies of cultured fibroblasts. J Pediatr. 1971 May;78(5):833–836. doi: 10.1016/s0022-3476(71)80355-4. [DOI] [PubMed] [Google Scholar]
  25. Schulman J. D., Schneider J. A., Bradley K. H., Seegmiller J. E. Cystine, cysteine, and glutathione metabolism in normal and cystinotic fibroblasts in vitro, and in cultured normal amniotic fluid cells. Clin Chim Acta. 1972 Mar;37:53–58. doi: 10.1016/0009-8981(72)90415-9. [DOI] [PubMed] [Google Scholar]
  26. Skrede S. The mechanism of disulphide reduction by mitochondria. Biochem J. 1968 Jul;108(4):693–699. doi: 10.1042/bj1080693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tomono I., Abe M., Matsuda M. Effect of penicillamine (a vitamin B6 antagonist) on pyridoxal enzymes. J Biochem. 1973 Sep;74(3):587–592. doi: 10.1093/oxfordjournals.jbchem.a130280. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES